Overview
Detailed Intelligence on Global Pharmaceutical & Biotech Projects, Plants & Labs
Industrial Info’s Pharmaceutical & Biotech Industry Database and Market Analytics Platform delivers detailed business intelligence across manufacturing, research laboratories, diagnostics, and supply chain operations. Our platform helps you track plant activity, monitor capital maintenance projects, and connect with key decision-makers across every major segment of the global life sciences industry.
Global Pharmaceutical & Biotech Industry Coverage
Segment-Level Coverage
Track facilities and projects across pharmaceuticals, biologics, diagnostics, nutritionals, cosmetics, medical devices, and cannabis-based therapies.
Facility Intelligence
Access data on operational, pre-commissioned, and decommissioned plants and laboratories, including ownership, function, and site-level contacts.
Plant Types Tracked
View activity across clinical-scale, commercial-scale, CDMOs, CMOs, analytical labs, and packaging and distribution centers.
Project Types
Monitor grassroots builds, facility expansions, in-plant capital improvements, and maintenance agreements, including LTSAs.
Global Scope, Local Detail
Follow investment activity across North America, Europe, Asia, and Latin America, down to the equipment need, job creation potential, and project timelines.
Contractor & Contact Insights
See awarded contractors, vendor relationships, and direct points of contact for business development and sourcing teams.
Key Features
Sectors We Cover Across the Pharmaceutical & Biotech Lifecycle
Research, Design & Development
Monitor early-stage R&D labs, product development centers, and analytical testing sites across both institutional and commercial sectors.
API & Ingredient Manufacturing
Track production of active pharmaceutical ingredients (APIs), bulk excipients, and plant-based compounds for use in all drug types and therapeutic categories.
Biologicals (Upstream & Downstream)
Follow cell culture, fermentation, and harvest activities in upstream biologics, along with purification and downstream processing tied to gene therapy, cell therapy, and vaccine manufacturing.
Formulation, Fill & Finish
Pinpoint capital and maintenance projects tied to oral dose, injectable, and other finished dosage forms, including contract manufacturing and CMO & CDMO activity.
Packaging Operations
Track packaging plants supporting both small- and large-molecule drugs, including sterilization, labeling, and life science packaging initiatives.
Distribution & Warehousing
Follow the development of cold storage, general warehousing, and logistics hubs supporting the global life sciences supply chain.
Who We Serve
Where Pharma & Biotech Professionals Go for Reliable Data and Market Intelligence
Our platform is trusted by leaders across life sciences who need to track investment, monitor innovation, and connect with the right people, at the right time.
Forecast Chart Preview
Sales & Business Development Teams
- Identify capital projects across biologics, pharma, packaging, and logistics.
- Reach decision-makers at CDMOs, CMOs, and clinical/commercial facilities.
- Time your outreach to align with project phase, scope, and equipment needs.
Strategic Planning & Competitive Intelligence Monitoring
- Track global investment in drug development, green manufacturing, and advanced therapies.
- Benchmark facility growth by therapeutic area, dosage form, or production scale.
- Analyze regional trends in biologics, AI-powered labs, and decentralized supply chains.
Suppliers, EPCs & Service Providers
- Discover opportunities tied to lab buildouts, facility expansions, and packaging plants.
- Monitor awarded contractors and long-term maintenance agreements.
- Understand site-level needs, timelines, and scope to position your solutions early.
Value & Impact
What You Can Do with IIR’s Pharmaceutical & Biotech Data
Whether you’re selling into clinical manufacturing, planning supply chain expansion, or monitoring drug production trends, our platform delivers the trusted data you need to take action with confidence.
Identify High-Value Projects Early
Spot new-builds, expansions, and capital improvements across pharma, biotech, and medical device manufacturing, before your competitors do.
Connect with Decision-Makers
Access verified contacts at CDMOs, CMOs, labs, and production facilities to streamline outreach and shorten your sales cycle.
Track Innovation & Investment Trends
Follow spending on biologics, personalized medicine, green manufacturing, and emerging technologies like gene-editing and AI-enabled drug discovery.
Support Smarter Strategic Planning
Use dashboards and analytics to benchmark markets, prioritize outreach, and respond faster to evolving facility and supply chain needs.
Getting Started
Start Smart. Start Risk-Free.
Request a Consultation
Meet 1:1 with an IIR representative to see how our Pharmaceutical & Biotech platform can help you uncover high-value opportunities, align with innovation trends, and move faster in a complex, regulated market.
Trusted Data You Can Depend On
Our data is built on direct research and validated by industry specialists, giving you a constantly updated view of global pharma and biotech projects, facilities, and investments.
Premium Ongoing Support
From onboarding to custom dashboards, our support team helps your organization extract maximum value, whether you’re selling, building, or planning in the life sciences ecosystem.
Featured Content
Insights from Our Experts
What our experts are seeing in capital trends, innovation, and market shifts.
Annette Kruger
Sr. VP, Pharma & Bio-Tech ResearchPharma’s Investment Surge Is Reshaping Global Supply Chains
Amid rising demand, trade tensions, and breakthrough therapies, the pharmaceutical and biotech industry is doubling down on strategic capital spending. From smart campuses to biologics expansions, the momentum shows no sign of slowing.
Investment Booms in GLP-1 and Gene Therapy Facilities
Top pharma players are pouring billions into U.S. manufacturing campuses to expand capacity for high-value weight-loss and genetic therapies, insulated from supply chain risks and global tariffs.
Europe Holds Steady, But Hesitation Grows Amid Tariff Uncertainty
Over $89B in projects are still active in Europe, but new announcements are slowing as firms await clarity on U.S. trade policies, especially in Ireland, the UK, and the DACH region.
Reshoring Picks Up Pace, Driven by Profit Protection
U.S. remains the leader in drug R&D, and companies are increasingly expanding in place to protect their most lucrative therapies, reduce risk, and gain tax advantages.
CMOs & CDMOs Back in the Spotlight Post-COVID
After a cooldown, contract manufacturers like Thermo Fisher and Lonza are ramping up again as drug makers seek flexible, lower-risk production partners to meet market demand.
Automation & AI Take Center Stage in Modern Drug Manufacturing
Pharma 4.0 is here. From blockchain traceability to AI-powered MES systems, firms are investing in smart plants that minimize human error and maximize efficiency at every step of production.
Industry News Digest
Fallback Title Here
Industry Tour
Explore What Our Pharmaceutical & Biotech Database and Market Intelligence Platform Has To Offer
Strategic Market Insights
AI, Robotics, and the New Era of Pharma Production
Contact Us
Request A Consultation
Or call us now at +1 (800) 762-3361
Discover how IIR’s Global Pharmaceutical & Biotech Industry Intelligence Database and Market Analytics Platform can support your business,whether you’re tracking capital investments in biologics, navigating the evolving CMO/CDMO landscape, or aligning strategy with global regulatory trends.
With offices in Europe, Latin America, Asia-Pacific, Australia, and the United States, our experts provide region-specific insight backed by continuously verified global data.
Fill out the form, and one of our regional pharmaceutical and biotech industry specialists will contact you to schedule your consultation.
Why Industry Leaders Worldwide Trust IIR
- Trusted by pharmaceutical manufacturers, biotech innovators, and CDMOs worldwide
- Personalized onboarding and strategic guidance from sector experts
- Continuously updated data on global projects, plants, and expansions
- Proprietary insights into drug production trends, equipment needs, and investment cycles
